Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Carpenter

Showing results (71-80 of 178) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host diseasePaul A Carpenter, James Lowder, Laura Johnston, et al.
Transplantation and Cellular Therapy|February 9, 2025
American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation RecipientsAbby P Douglas, Frederic Lamoth, Teny M John, et al.
Transplantation and Cellular Therapy|March 25, 2026
Fear of cancer recurrence in hematopoietic cell transplantation survivors: fear of cancer recurrence in HCT survivorsEmily C Liang, Megan J Shen, Rachel B Salit, et al.
British Journal of Haematology|April 27, 2012
Success of allogeneic marrow transplantation for children with severe aplastic anaemiaLauri M Burroughs, Ann E Woolfrey, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantationStephanie J Lee, Travis Seaborn, Frances J Mao, et al.
Blood Advances|April 1, 2020
Late infectious complications in hematopoietic cell transplantation survivors: a population-based studyAimee M Foord, Kara L Cushing-Haugen, Michael J Boeckh, et al.
Transplantation and Cellular Therapy|April 14, 2024
ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell TherapyHamza Hashmi, Ambuj Kumar, Mohamed A Kharfan-Dabaja, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 7, 2024
Barriers and facilitators to routine revaccination among adult Hematopoietic Cell Transplant survivors in the United States: A convergent mixed methods analysisMihkai Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2017
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseaseStephanie J Lee, Tam D Nguyen, Lynn Onstad, et al.
Blood Advances|September 18, 2025
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 yearsAnna C Ferreira, Debjani Dutta, Courtney M Rowan, et al.
Pageof 18

Showing results (71-80 of 178) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host diseasePaul A Carpenter, James Lowder, Laura Johnston, et al.
Transplantation and Cellular Therapy|February 9, 2025
American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation RecipientsAbby P Douglas, Frederic Lamoth, Teny M John, et al.
Transplantation and Cellular Therapy|March 25, 2026
Fear of cancer recurrence in hematopoietic cell transplantation survivors: fear of cancer recurrence in HCT survivorsEmily C Liang, Megan J Shen, Rachel B Salit, et al.
British Journal of Haematology|April 27, 2012
Success of allogeneic marrow transplantation for children with severe aplastic anaemiaLauri M Burroughs, Ann E Woolfrey, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantationStephanie J Lee, Travis Seaborn, Frances J Mao, et al.
Blood Advances|April 1, 2020
Late infectious complications in hematopoietic cell transplantation survivors: a population-based studyAimee M Foord, Kara L Cushing-Haugen, Michael J Boeckh, et al.
Transplantation and Cellular Therapy|April 14, 2024
ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell TherapyHamza Hashmi, Ambuj Kumar, Mohamed A Kharfan-Dabaja, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 7, 2024
Barriers and facilitators to routine revaccination among adult Hematopoietic Cell Transplant survivors in the United States: A convergent mixed methods analysisMihkai Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2017
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseaseStephanie J Lee, Tam D Nguyen, Lynn Onstad, et al.
Blood Advances|September 18, 2025
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 yearsAnna C Ferreira, Debjani Dutta, Courtney M Rowan, et al.
Pageof 18